I just want to make some sense of the efficacy claims from studies to real world for instance Pfizer in Israel produced real world figures on transmission that closely matched the efficacy in trials of close to 95% ,so just trying to see if ours comes out at around 60-65%.
Anyone numerate enough to run the calcs if it's at all possible to measure if the vaccines efficacy of circa 60% stacks up to a similar level re onward transmission ?
I see the express has another article about state pensions and the unlikely chance of the qualifying age being reduced, quelle suprise.
Just so happened that i was again having this conversation on Friday evening with a former workmate around the fact that there is absolutely no consideration...
What is all the commotion around work absence and shortages, Christ we got through the first wave.
Better get your 18 roll packs of bogroll in, keep Astute on plenty of overtime.
So what about France and the bit of a stink about isolating on return from there?
I thought the beta variant was around the same level as the kent variant?
"GB News turns to Nigel Farage as its saviour after ratings freefall | GB News | The Guardian" GB News turns to Nigel Farage as its saviour after ratings freefall | GB News | The Guardian
Regards the quasi effective argument there are article's questioning the antibody levels of the older generation .
Re kid's without being alarmist barely anyone seems to take into account the potential of a mutation that does become life threatening to them.
Rather a blind spot in the equation...
Hey missed this.
Congratulations WM.
Of course you know the answer to the office space ,a garden Room /pod, with no gastly commute for the majority of your business.